Left atrial appendage closure: which patients benefit most?

Chairperson: Maurice BUCHBINDER, Alec VAHANIAN


To learn which patients may benefit from left atrial appendage closure
To understand how to best balance the risk of stroke and bleeding in specific patient groups
To know the latest clinical evidence, guidelines and expert consensus recommendations on left atrial appendage closure


Session objectives

M. Buchbinder

"My patient had a stroke and cannot take oral anticoagulation long-term"

M.W. Bergmann

"My patient has severe renal failure and a high CHA2DS2-VASc score"

I. Cruz-Gonzalez

"My patient has a stent and a high stroke risk"

H. Sievert

More from Boston Scientific

Wrap up:
Role of LAA Closure therapy in stroke prevention for patients with Atrial Fibrillation

Discussants: Ted FELDMAN, Martin BERGMANN

The Lotus valve: advancing treatment options for patients with challenging anatomies

Chairperson: Ted Feldman

Optimal healing and DAPT duration in today’s complex PCI: the Synergy stent

Chairperson: Ian T. MEREDITH
Visit website